New York State Common Retirement Fund
GYRE icon

New York State Common Retirement Fund’s Gyre Therapeutics GYRE Stock Holding History

New York State Common Retirement Fund’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Hold
2,700
– – ﹤0.01% 3130
2026
Q1 		$18.8K Hold
2,700
– – ﹤0.01% 3018
2025
Q4 		$19.1K Hold
2,700
– – ﹤0.01% 3095
2025
Q3 		$20.1K Hold
2,700
– – ﹤0.01% 3106
2025
Q2 		$19.8K Hold
2,700
– – ﹤0.01% 3120
2025
Q1 		$20.8K Hold
2,700
– – ﹤0.01% 2971
2024
Q4 		$32.7K Hold
2,700
– – ﹤0.01% 2960
2024
Q3 		$33.9K Sell
2,700
-7,500
-74% -$96.7K ﹤0.01% 2966
2024
Q2 		$122K Buy
+10,200
New +$140K ﹤0.01% 2654
2021
Q3 		– Sell
-34
Closed -$1K – 3429
2021
Q2 		$1K Sell
34
-2,099
-98% -$72K ﹤0.01% 3418
2021
Q1 		$81K Hold
2,133
– – ﹤0.01% 3120
2020
Q4 		$101K Hold
2,133
– – ﹤0.01% 3020
2020
Q3 		$69K Hold
2,133
– – ﹤0.01% 3074
2020
Q2 		$94K Buy
+2,133
New +$100K ﹤0.01% 3003
2019
Q2 		– Sell
-747
Closed -$45K – 3270
2019
Q1 		$45K Sell
747
-1,013
-58% -$65.1K ﹤0.01% 3081
2018
Q4 		$104K Hold
1,760
– – ﹤0.01% 2954
2018
Q3 		$142K Hold
1,760
– – ﹤0.01% 2972
2018
Q2 		$154K Buy
+1,760
New +$309K ﹤0.01% 2990

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

New York State Common Retirement Fund's GYRE Position: Q2 2026 in Review

New York State Common Retirement Fund held its Gyre Therapeutics (GYRE) position steady in Q2 2026 at 2,700 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

New York State Common Retirement Fund first reported a position in GYRE in Q2 2018 and has held it in 18 quarters since. The position peaked at $154K in Q2 2018. 59 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • New York State Common Retirement Fund held 2,700 shares of Gyre Therapeutics worth $17.8K as of Q2 2026.
  • New York State Common Retirement Fund left its Gyre Therapeutics share count unchanged in Q2 2026.
  • Gyre Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3130 holding.
  • New York State Common Retirement Fund first reported a position in Gyre Therapeutics in Q2 2018 and has held it in 18 quarters since.
  • New York State Common Retirement Fund's Gyre Therapeutics position peaked at $154K in Q2 2018.
  • 59 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.